MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hereditary spastic paraplegia caused by heterozygous AFG3L2 and SPG7 mutations

C.D. Stephen, J.D. Schmahmann (Boston, MA, USA)

Meeting: 2016 International Congress

Abstract Number: 1081

Keywords: Ataxia: Genetics, Spasticity: Genetics

Session Information

Date: Wednesday, June 22, 2016

Session Title: Ataxia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To report a new late-onset autosomal recessive spastic paraplegia caused by heterozygous mutations in the AFG3L2 and SPG7 genes.

Background: The hereditary spastic paraplegias (HSP) are a clinically heterogeneous group of disorders characterized by progressive lower extremity spasticity and weakness. Paraplegin is a mitochondrial protein and subunit of the mitochondrial matrix protease (m-AAA protease), which is mutated in SPG7 and causes an autosomal recessive HSP. AFG3L2 encodes another subunit of the m-AAA protease which is highly expressed in Purkinje cells. Pathogenic variants generally cause juvenile to early-adult onset autosomal dominant spinocerebellar ataxia, SCA28. AFG3L2 and paraplegin complex and interact with each other and can modulate disease presentation.

Methods: At age 48, the patient developed a slowly progressive spastic paraparesis with occasional falls and some bladder dysfunction. On examination 6 years into her disease, she had a mild lower extremity predominant spastic paraparesis with no evidence of cerebellar ataxia. She has no family history of spasticity or cerebellar ataxia.

Results: Brain MRI revealed isolated mild cerebellar atrophy. Exome sequencing revealed a heterozygous A510V mutation [c.1529C>T,p.Ala510Val] in the SPG7 gene and a heterozygous Y616C variant likely mutation [c.1847A>G,p.Tyr616Cys] in the AFG3L2 gene. She inherited the A510V mutation in the SPG7 gene from her mother and the Y616C mutation in the AFG3L2 gene from her father. Both parents are neurologically healthy.

Conclusions: Paraplegin is incapable of self-assembly into homo-oligomers and requires AFG3L2 for function. In addition, although most ALFG3L2 mutations cause autosomal dominant ataxia, the Y616C variant produces a severe phenotype of spastic-ataxia-neuropathy syndrome (SPAX-5), but only in the homozygous state (autosomal recessive inheritance). Functional studies have revealed impaired oligomerization with both the AFG3L2 protein and paraplegin. Therefore, our hypothesis is that in this patient, the AFG3L2 mutation in combination with the presence of a single mutated SPG7 allele produced an affected phenotype resembling SPG7 as result of synergistic partial loss-of-function effect and impaired protein interaction of both alleles.

To cite this abstract in AMA style:

C.D. Stephen, J.D. Schmahmann. Hereditary spastic paraplegia caused by heterozygous AFG3L2 and SPG7 mutations [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/hereditary-spastic-paraplegia-caused-by-heterozygous-afg3l2-and-spg7-mutations/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hereditary-spastic-paraplegia-caused-by-heterozygous-afg3l2-and-spg7-mutations/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley